Mining severe drug-drug interaction adverse events using Semantic Web technologies: a case study

被引:17
|
作者
Jiang, Guoqian [1 ]
Liu, Hongfang [1 ]
Solbrig, Harold R. [1 ]
Chute, Christopher G. [1 ]
机构
[1] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA
来源
BIODATA MINING | 2015年 / 8卷
关键词
Drug-drug Interaction; Adverse drug event; Data mining; Semantic web technology; Electronic medical records; KNOWLEDGE-BASE; REPORTING DATA; PHARMACOGENOMICS;
D O I
10.1186/s13040-015-0044-6
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Drug-drug interactions (DDIs) are a major contributing factor for unexpected adverse drug events (ADEs). However, few of knowledge resources cover the severity information of ADEs that is critical for prioritizing the medical need. The objective of the study is to develop and evaluate a Semantic Web-based approach for mining severe DDI-induced ADEs. Methods: We utilized a normalized FDA Adverse Event Report System (AERS) dataset and performed a case study of three frequently prescribed cardiovascular drugs: Warfarin, Clopidogrel and Simvastatin. We extracted putative DDI-ADE pairs and their associated outcome codes. We developed a pipeline to filter the associations using ADE datasets from SIDER and PharmGKB. We also performed a signal enrichment using electronic medical records (EMR) data. We leveraged the Common Terminology Criteria for Adverse Event (CTCAE) grading system and classified the DDI-induced ADEs into the CTCAE in the Web Ontology Language (OWL). Results: We identified 601 DDI-ADE pairs for the three drugs using the filtering pipeline, of which 61 pairs are in Grade 5, 56 pairs in Grade 4 and 484 pairs in Grade 3. Among 601 pairs, the signals of 59 DDI-ADE pairs were identified from the EMR data. Conclusions: The approach developed could be generalized to detect the signals of putative severe ADEs induced by DDIs in other drug domains and would be useful for supporting translational and pharmacovigilance study of severe ADEs.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Identifying Adverse Drug Reactions Associated with Drug-Drug InteractionsData Mining of a Spontaneous Reporting Database in Italy
    Roberto Leone
    Lara Magro
    Ugo Moretti
    Paola Cutroneo
    Martina Moschini
    Domenico Motola
    Marco Tuccori
    Anita Conforti
    Drug Safety, 2010, 33 : 667 - 675
  • [42] Drug-drug interaction in patients using proton pump inhibitors: a patient drug profile study
    Karasakal, Y. E.
    Sancar, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 483 - 483
  • [43] Molecular mechanism of an adverse drug-drug interaction of allopurinol and furosemide in gout treatment
    Knake, Claudia
    Stamp, Lisa
    Bahn, Andrew
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 452 (01) : 157 - 162
  • [44] Multitask Dyadic Prediction and Its Application in Prediction of Adverse Drug-Drug Interaction
    Jin, Bo
    Yang, Haoyu
    Xiao, Cao
    Zhang, Ping
    Wei, Xiaopeng
    Wang, Fei
    THIRTY-FIRST AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE, 2017, : 1367 - 1373
  • [45] Applying Semantic Web technologies to drug safety determination
    Stephens, S
    Morales, A
    Quinlan, M
    IEEE INTELLIGENT SYSTEMS, 2006, 21 (01) : 82 - 86
  • [46] Systems pharmacology analysis of oncology drug combinations to evaluate adverse events due to drug-drug interactions
    Kim, Sarah
    Lahu, Gezim
    Lesko, Lawrence J.
    Trame, Mirjam N.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S115 - S116
  • [48] Case report: Medical cannabis—warfarin drug-drug interaction
    Tyan F. Thomas
    Evdokia S. Metaxas
    Thu Nguyen
    Whitni Bennett
    Kathryn V. Skiendzielewski
    Diane H. Quinn
    Alice L. Scaletta
    Journal of Cannabis Research, 4